Abstract
Objective Aortic stenosis has traditionally been addressed with surgical
aortic valve replacement with a stented prosthesis. Several technologies
have emerged as an alternative treatment method for aortic valve
disease. Among them, Perceval Sutureless valve has been used in clinical
practice for more than a decade. The aim of this study was to evaluate
the results of Perceval Sutureless valve from single centre in Indian
population. Method Between April 2018 to December 2021, 30 elective
patients underwent aortic valve replacement with the Perceval Sutureless
valve. 19 patients had isolated AVR and 11 patients underwent AVR +
Coronary artery bypass grafting (CABG) with average grafts 2.1 ± 0.8.
Majority of isolated AVR, 12 of 19, were done by minimally invasive
approach. Result Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ±
1.5. Mean aortic cross clamp time for isolated AVR and combined
procedure were 42 ± 11 and 74 ± 23 respectively. There was no
in-hospital mortality. 3 patients required ventilation for
> 24 hours. New onset left bundle branch block occurred in
4 patients which recovered before discharge in 2 patients. The peak and
mean valve gradients were satisfactory. None of implanted valve showed
para-valvular leak. Conclusion SAVR using Perceval Sutureless valve is
associated with excellent results and represent a safe and effective
treatment option for patients with severe AS. This valve also
facilitates MI approach and reduces aortic x-clamp and cardiopulmonary
bypass time.